SAS Programming in the Pharmaceutical Industry, Second Edition
Description:
This one-stop resource offers a complete review of what entry- to intermediate-level statistical programmers need to know in order to help with the analysis and reporting of clinical trial data in the pharmaceutical industry.
SAS Programming in the Pharmaceutical Industry, Second Edition begins with an introduction to the pharmaceutical industry and the work environment of a statistical programmer. Then it gives a chronological explanation of what you need to know to do the job. It includes information on importing and massaging data into analysis data sets, producing clinical trial output, and exporting data. This edition has been updated for SAS 9.4, and it features new graphics as well as all new examples using CDISC SDTM or ADaM model data structures.
Whether you're a novice seeking an introduction to SAS programming in the pharmaceutical industry or a junior-level programmer exploring new approaches to problem solving, this real-world reference guide offers a wealth of practical suggestions to help you sharpen your skills.
This book is part of the SAS Press program.
Best prices to buy, sell, or rent ISBN 9781635269147
Frequently Asked Questions about SAS Programming in the Pharmaceutical Industry, Second Edition
The price for the book starts from $85.17 on Amazon and is available from 11 sellers at the moment.
If you’re interested in selling back the SAS Programming in the Pharmaceutical Industry, Second Edition book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the SAS Programming in the Pharmaceutical Industry, Second Edition book, the best buyback offer comes from and is $ for the book in good condition.
The SAS Programming in the Pharmaceutical Industry, Second Edition book is in very low demand now as the rank for the book is 5,469,344 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.